Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss drug through partnerships with third-party ...
In summary, under the Trump plan, the U.S. health system continues to fail Americans — by not viewing obesity as a disease, ...
Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback